(Q33231889)

24 July 2017

title

Anti-IgG autoantibodies in HIV-infected hemophilia patients (English)

1 reference

24 July 2017

Anti-IgG Autoantibodies in HIV-infected Hemophilia Patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

20 October 2022

0 references

1 reference

Huth-Kühne A

7

1 reference

24 July 2017

C. Süsal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

I. V. Lewin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

D. R. Stanworth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

P. Terness

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

V. Daniel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

H. H. Oberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

A. Huth-Kühne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

R. Zimmermann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

G. Opelz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642003

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642003

20 October 2022

publication date

1 January 1992

1 reference

full work available at URL

24 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1423-0410.1992.tb01203.x

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.1992.tb01203.x/fullpdf

20 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

20 October 2022

1 reference

24 July 2017

volume

62

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

224-229

1 reference

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

24 July 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0092-8674(86)90590-8

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states

20 October 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

20 October 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

20 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Anti-viral antibodies in HIV (HTLV-III) infection possess auto-antibody activity against a CH1 domain determinant in human IgG: possible immunological consequences.

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

A B cell-suppressive IgG-antiimmunoglobulin antibody induced by alloimmunization

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Immunologic thrombocytopenic purpura in HIV-seropositive homosexuals, narcotic addicts and hemophiliacs

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Transfusion-associated acquired immunodeficiency syndrome in the United States

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

The epidemiology of AIDS: current status and future prospects

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients

20 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Autoimmune diseases: immunopathology and etiopathogenesis

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Medical consequences of persistent viral infection

20 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Retrovirus-like sequences in Graves' disease: implications for human autoimmunity

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression

20 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Correlation of immune defects in hemophilia with HTLV-III antibody titers

20 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

20 October 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

B-cell immunodeficiency in acquired immune deficiency syndrome

20 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations

20 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes

20 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome

20 October 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors

20 October 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Immunoregulation by Fc signals A mechanism for self-nonself discrimination

20 October 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

Rheumatoid factor and Fc signaling: a tale of two Cinderellas

20 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1992.TB01203.X

20 October 2022

Identifiers

1 reference

24 July 2017

1 reference